X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (902) 902
Newsletter (61) 61
Publication (59) 59
Book Review (10) 10
Magazine Article (10) 10
Book / eBook (4) 4
Trade Publication Article (2) 2
Book Chapter (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (767) 767
ophthalmology (518) 518
scleritis - drug therapy (516) 516
female (484) 484
scleritis (459) 459
male (411) 411
middle aged (372) 372
adult (295) 295
aged (280) 280
index medicus (272) 272
scleritis - diagnosis (246) 246
scleritis - etiology (193) 193
immunosuppressive agents - therapeutic use (153) 153
treatment outcome (148) 148
uveitis (135) 135
drug therapy, combination (132) 132
retrospective studies (130) 130
glucocorticoids - therapeutic use (129) 129
care and treatment (113) 113
aged, 80 and over (111) 111
visual acuity (111) 111
disease (93) 93
therapy (92) 92
eye diseases (91) 91
adolescent (90) 90
episcleritis (88) 88
scleritis - complications (88) 88
scleritis - microbiology (88) 88
scleritis - pathology (86) 86
follow-up studies (84) 84
diagnosis (81) 81
anti-inflammatory agents - therapeutic use (76) 76
diagnosis, differential (74) 74
inflammation (72) 72
keratitis (71) 71
uveitis - drug therapy (70) 70
anti-inflammatory agents, non-steroidal - therapeutic use (67) 67
anti-bacterial agents - therapeutic use (66) 66
recurrence (64) 64
rheumatology (64) 64
posterior scleritis (60) 60
child (59) 59
rheumatoid-arthritis (58) 58
infliximab (57) 57
necrotizing scleritis (57) 57
research (57) 57
prednisolone - therapeutic use (56) 56
prednisone - therapeutic use (56) 56
rituximab (56) 56
rheumatoid arthritis (54) 54
ultrasonography (52) 52
antibodies, monoclonal - therapeutic use (51) 51
risk factors (51) 51
surgery (51) 51
drug therapy (50) 50
eye infections, bacterial - drug therapy (50) 50
corticosteroids (49) 49
fluorescein angiography (49) 49
adrenal cortex hormones - therapeutic use (48) 48
young adult (45) 45
eye infections, bacterial - microbiology (44) 44
keratitis - drug therapy (43) 43
sclera - pathology (43) 43
medicine & public health (42) 42
arthritis, rheumatoid - complications (41) 41
case report (40) 40
case studies (40) 40
corneal ulcer - drug therapy (40) 40
cyclophosphamide - therapeutic use (39) 39
eye (39) 39
prognosis (39) 39
abridged index medicus (38) 38
drugs (38) 38
infectious scleritis (38) 38
scleritis - immunology (38) 38
health aspects (37) 37
management (37) 37
clinical-features (36) 36
scleritis - physiopathology (36) 36
genetic structures (35) 35
granulomatosis with polyangiitis - drug therapy (35) 35
patients (35) 35
administration, oral (34) 34
medicine, general & internal (34) 34
eye infections, bacterial - diagnosis (33) 33
peripheral ulcerative keratitis (33) 33
glucocorticoids - administration & dosage (32) 32
scleritis - diagnostic imaging (32) 32
scleritis - therapy (32) 32
vasculitis (32) 32
arthritis (31) 31
article (31) 31
complications and side effects (31) 31
glaucoma (31) 31
immunosuppressive agents - administration & dosage (31) 31
steroids (31) 31
tumor necrosis factor-alpha - antagonists & inhibitors (31) 31
sense organs (30) 30
tomography, x-ray computed (30) 30
arthritis, rheumatoid - drug therapy (29) 29
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (898) 898
French (22) 22
German (16) 16
Spanish (15) 15
Portuguese (10) 10
Polish (6) 6
Chinese (3) 3
Russian (3) 3
Danish (2) 2
Romanian (2) 2
Finnish (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 21, pp. 2691 - 2697
Monoclonal antibodies directed against the immune checkpoint protein cytotoxic T-lymphocyte antigen-4 (CTLA-4; CD152)-ipilimumab and tremelimumab-have been... 
REGRESSION | METASTATIC MELANOMA | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | EFFICACY | ONCOLOGY | PHASE-II | MONOCLONAL-ANTIBODY | CTLA-4 | PATIENT | CANCER-IMMUNOTHERAPY | BLOCKADE | Stevens-Johnson Syndrome - immunology | Peripheral Nervous System Diseases - chemically induced | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Scleritis - chemically induced | Antineoplastic Agents - administration & dosage | Liver - immunology | Liver - drug effects | Antineoplastic Agents - adverse effects | Diarrhea - immunology | Pancreatitis - immunology | Scleritis - immunology | Mucous Membrane - drug effects | Colitis - immunology | Peripheral Nervous System Diseases - immunology | Antibodies, Monoclonal - immunology | Drug Eruptions - immunology | Skin - immunology | Melanoma - metabolism | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Antineoplastic Agents - immunology | CTLA-4 Antigen - drug effects | Lymphatic Diseases - immunology | Antibodies, Monoclonal - pharmacokinetics | CTLA-4 Antigen - immunology | Pancreatitis - chemically induced | Melanoma - secondary | Chemical and Drug Induced Liver Injury - immunology | Pituitary Gland - immunology | Skin Neoplasms - metabolism | Lymphatic Diseases - chemically induced | Mucous Membrane - immunology | Antibodies, Monoclonal - administration & dosage | Melanoma - immunology | Uveitis - immunology | Melanoma - drug therapy | Uveitis - chemically induced | Pituitary Gland - drug effects | Skin - drug effects | Index Medicus
Journal Article
Journal Article
Ophthalmology, ISSN 0161-6420, 2010, Volume 117, Issue 2, pp. 356 - 365
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2009, Volume 148, Issue 4, pp. 500 - 509.e2
Journal Article
Clinical Rheumatology, ISSN 0770-3198, 10/2017, Volume 36, Issue 10, pp. 2307 - 2318
Interleukin (IL)-1 plays a key role in the pathogenesis and thereafter in the search for specific treatments of different inflammatory and degenerative eye... 
Dry-eye | Macular degeneration | Scleritis | Diabetic retinopathy | Keratitis | Uveitis | PRIMARY SJOGRENS-SYNDROME | ANAKINRA TREATMENT | ANTERIOR SCLERITIS | BEHCETS-DISEASE | RHEUMATOLOGY | CORNEAL TRANSPLANTATION | IL-1 RECEPTOR ANTAGONIST | CASE SERIES | AUTOIMMUNE-DISEASE | RETINITIS-PIGMENTOSA | Dry Eye Syndromes - immunology | Keratitis - immunology | Macular Degeneration - immunology | Humans | Sjogren's Syndrome - immunology | Macular Degeneration - drug therapy | Inflammation - drug therapy | Interleukin 1 Receptor Antagonist Protein - metabolism | Interleukin-1 - physiology | Scleritis - drug therapy | Scleritis - immunology | Disease Models, Animal | Eye Diseases - immunology | Dry Eye Syndromes - drug therapy | NLR Family, Pyrin Domain-Containing 3 Protein - metabolism | Sjogren's Syndrome - drug therapy | Uveitis - drug therapy | Hereditary Autoinflammatory Diseases - immunology | Inflammation - immunology | Hereditary Autoinflammatory Diseases - drug therapy | Animals | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Uveitis - immunology | Eye Diseases - drug therapy | Keratitis - drug therapy | Medical research | Care and treatment | Interleukins | Analysis | Medicine, Experimental | Ophthalmology | Health aspects | Eye | Animal models | Cytokines | Cryopyrin | Pathogenesis | Interleukin 1 receptor antagonist | Interleukin 1 | Eye diseases | Diabetes
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2010, Volume 149, Issue 3, pp. 423 - 432.e2
Journal Article
Journal Article